Original research
by
Mocanu, Victor et al
Release Date
2023
Geography
Canada
Language of Resource
English
Full Text Available
No
Open Access / OK to Reproduce
No
Peer Reviewed
Yes
Objective
This study evaluated the impact of initial randomized OAT allocation on subsequent switching among people with prescription-type opioid use disorder (POUD).
Findings/Key points
OAT switching was common in this sample of individuals with POUD, with individuals randomly allocated to buprenorphine/naloxone being more than twice as likely to switch versus methadone. This may reflect a stepped care approach in OUD management.
Design/methods
Secondary analysis of a 24-week Canadian multicenter, pragmatic, randomized trial conducted (n=272) between 2017 and 2020 comparing flexible take-home buprenorphine/naloxone versus supervised methadone models of care for POUD
Keywords
Substitution/OAT
Transitions in care/treatment
